UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015467
Receipt number R000017967
Scientific Title Phase II study of erlotinib plus bevacizumab and inserted cisplatin, pemetrexed plus bevacizumab as a 1st-line treatment for advanced non-squamous, non-small cell lung cancer harboring activating EGFR mutations
Date of disclosure of the study information 2014/10/18
Last modified on 2018/10/21 20:57:18

No. Disposal Last modified on Item of update
1 Insert 2014/10/18 13:43:53
2 Update 2015/11/16 14:13:23 Email1
3 Update 2016/07/31 15:09:42 Name of primary person or sponsor
Institute
Department
Organization
Organization
Division
4 Update 2017/10/20 12:19:38 Recruitment status
Date analysis concluded
5 Update 2018/10/21 20:57:18 Recruitment status